GPC1 and prostate carcinoma: The increase in paracrine activation of markers of cancer progressiveness in prostate cancer cells and the change their in cell morphology, following exposure to HS-5 cells in which GPC-1 was inhibited suggests that GPC-1 loss indirectly promotes an aggressive prostate cancer phenotype.